Tartrate-resistant acid phosphatase (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tartrate-resistant acid phosphatase" in English language version.

refsWebsite

Global rank English rank

20nih.gov

4^th place

17doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1biologists.org

3,870^th place

3,434^th place

1omim.org

4,380^th place

4,305^th place

1zenodo.org

621^st place

380^th place

biologists.org

dev.biologists.org

Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, et al. (October 1996). "Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis". Development. 122 (10): 3151–3162. doi:10.1242/dev.122.10.3151. PMID 8898228.

doi.org

Baumbach GA, Saunders PT, Ketcham CM, Bazer FW, Roberts RM (July 1991). "Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro". Molecular and Cellular Biochemistry. 105 (2): 107–117. doi:10.1007/bf00227750. PMID 1922010. S2CID 30416983.
Ljusberg J, Ek-Rylander B, Andersson G (October 1999). "Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases". The Biochemical Journal. 343 Pt 1 (1): 63–69. doi:10.1042/0264-6021:3430063. PMC 1220524. PMID 10493912.
Ljusberg J, Wang Y, Lång P, Norgård M, Dodds R, Hultenby K, et al. (August 2005). "Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts". The Journal of Biological Chemistry. 280 (31): 28370–28381. doi:10.1074/jbc.M502469200. PMID 15929988.
Klabunde T, Sträter N, Fröhlich R, Witzel H, Krebs B (June 1996). "Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures". Journal of Molecular Biology. 259 (4): 737–748. doi:10.1006/jmbi.1996.0354. PMID 8683579.
Burstone MS (January 1959). "Histochemical demonstration of acid phosphatase activity in osteoclasts". The Journal of Histochemistry and Cytochemistry. 7 (1): 39–41. doi:10.1177/7.1.39. PMID 13664936.
Minkin C (May 1982). "Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function". Calcified Tissue International. 34 (3): 285–290. doi:10.1007/BF02411252. PMID 6809291. S2CID 22706943.
Cassady AI, King AG, Cross NC, Hume DA (August 1993). "Isolation and characterization of the genes encoding mouse and human type-5 acid phosphatase". Gene. 130 (2): 201–207. doi:10.1016/0378-1119(93)90420-8. PMID 8359686.
Walsh NC, Cahill M, Carninci P, Kawai J, Okazaki Y, Hayashizaki Y, et al. (March 2003). "Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene". Gene. 307: 111–123. doi:10.1016/S0378-1119(03)00449-9. PMID 12706893.
Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, et al. (March 2000). "The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts". Journal of Bone and Mineral Research. 15 (3): 451–460. doi:10.1359/jbmr.2000.15.3.451. PMID 10750559. S2CID 24064612.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, et al. (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–676. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, et al. (October 1996). "Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis". Development. 122 (10): 3151–3162. doi:10.1242/dev.122.10.3151. PMID 8898228.
Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA (January 2000). "Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover". Journal of Bone and Mineral Research. 15 (1): 103–110. doi:10.1359/jbmr.2000.15.1.103. PMID 10646119. S2CID 35584934.
Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, et al. (February 2011). "Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity". Nature Genetics. 43 (2): 132–137. doi:10.1038/ng.749. PMID 21217752. S2CID 205357235.
Ek-Rylander B, Flores M, Wendel M, Heinegård D, Andersson G (May 1994). "Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro". The Journal of Biological Chemistry. 269 (21): 14853–14856. doi:10.1016/S0021-9258(17)36541-9. PMID 8195113.
Darden AG, Ries WL, Wolf WC, Rodriguiz RM, Key LL (May 1996). "Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase". Journal of Bone and Mineral Research. 11 (5): 671–675. doi:10.1002/jbmr.5650110515. PMID 9157782. S2CID 32443917.
Fenton HJ (1894). "LXXIII.—Oxidation of tartaric acid in presence of iron". Journal of the Chemical Society, Transactions. 65: 899–910. doi:10.1039/CT8946500899.
Sheu TJ, Schwarz EM, Martinez DA, O'Keefe RJ, Rosier RN, Zuscik MJ, Puzas JE (January 2003). "A phage display technique identifies a novel regulator of cell differentiation". The Journal of Biological Chemistry. 278 (1): 438–443. doi:10.1074/jbc.M208292200. PMID 12403789.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000102575 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000001348 – Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

Baumbach GA, Saunders PT, Ketcham CM, Bazer FW, Roberts RM (July 1991). "Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro". Molecular and Cellular Biochemistry. 105 (2): 107–117. doi:10.1007/bf00227750. PMID 1922010. S2CID 30416983.
Ljusberg J, Ek-Rylander B, Andersson G (October 1999). "Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases". The Biochemical Journal. 343 Pt 1 (1): 63–69. doi:10.1042/0264-6021:3430063. PMC 1220524. PMID 10493912.
Ljusberg J, Wang Y, Lång P, Norgård M, Dodds R, Hultenby K, et al. (August 2005). "Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts". The Journal of Biological Chemistry. 280 (31): 28370–28381. doi:10.1074/jbc.M502469200. PMID 15929988.
Klabunde T, Sträter N, Fröhlich R, Witzel H, Krebs B (June 1996). "Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures". Journal of Molecular Biology. 259 (4): 737–748. doi:10.1006/jmbi.1996.0354. PMID 8683579.
Burstone MS (January 1959). "Histochemical demonstration of acid phosphatase activity in osteoclasts". The Journal of Histochemistry and Cytochemistry. 7 (1): 39–41. doi:10.1177/7.1.39. PMID 13664936.
Minkin C (May 1982). "Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function". Calcified Tissue International. 34 (3): 285–290. doi:10.1007/BF02411252. PMID 6809291. S2CID 22706943.
Cassady AI, King AG, Cross NC, Hume DA (August 1993). "Isolation and characterization of the genes encoding mouse and human type-5 acid phosphatase". Gene. 130 (2): 201–207. doi:10.1016/0378-1119(93)90420-8. PMID 8359686.
Walsh NC, Cahill M, Carninci P, Kawai J, Okazaki Y, Hayashizaki Y, et al. (March 2003). "Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene". Gene. 307: 111–123. doi:10.1016/S0378-1119(03)00449-9. PMID 12706893.
Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, et al. (March 2000). "The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts". Journal of Bone and Mineral Research. 15 (3): 451–460. doi:10.1359/jbmr.2000.15.3.451. PMID 10750559. S2CID 24064612.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, et al. (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–676. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, et al. (October 1996). "Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis". Development. 122 (10): 3151–3162. doi:10.1242/dev.122.10.3151. PMID 8898228.
Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA (January 2000). "Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover". Journal of Bone and Mineral Research. 15 (1): 103–110. doi:10.1359/jbmr.2000.15.1.103. PMID 10646119. S2CID 35584934.
Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, et al. (February 2011). "Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity". Nature Genetics. 43 (2): 132–137. doi:10.1038/ng.749. PMID 21217752. S2CID 205357235.
Ek-Rylander B, Flores M, Wendel M, Heinegård D, Andersson G (May 1994). "Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro". The Journal of Biological Chemistry. 269 (21): 14853–14856. doi:10.1016/S0021-9258(17)36541-9. PMID 8195113.
Darden AG, Ries WL, Wolf WC, Rodriguiz RM, Key LL (May 1996). "Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase". Journal of Bone and Mineral Research. 11 (5): 671–675. doi:10.1002/jbmr.5650110515. PMID 9157782. S2CID 32443917.
Roberts RM, Raub TJ, Bazer FW (September 1986). "Role of uteroferrin in transplacental iron transport in the pig". Federation Proceedings. 45 (10): 2513–2518. PMID 3527760.
Sheu TJ, Schwarz EM, Martinez DA, O'Keefe RJ, Rosier RN, Zuscik MJ, Puzas JE (January 2003). "A phage display technique identifies a novel regulator of cell differentiation". The Journal of Biological Chemistry. 278 (1): 438–443. doi:10.1074/jbc.M208292200. PMID 12403789.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Ljusberg J, Ek-Rylander B, Andersson G (October 1999). "Tartrate-resistant purple acid phosphatase is synthesized as a latent proenzyme and activated by cysteine proteinases". The Biochemical Journal. 343 Pt 1 (1): 63–69. doi:10.1042/0264-6021:3430063. PMC 1220524. PMID 10493912.

omim.org

"Spondyloenchondrodysplasia With Immune Dysregulation; Spencdi". OMIM.

semanticscholar.org

api.semanticscholar.org

Baumbach GA, Saunders PT, Ketcham CM, Bazer FW, Roberts RM (July 1991). "Uteroferrin contains complex and high mannose-type oligosaccharides when synthesized in vitro". Molecular and Cellular Biochemistry. 105 (2): 107–117. doi:10.1007/bf00227750. PMID 1922010. S2CID 30416983.
Minkin C (May 1982). "Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function". Calcified Tissue International. 34 (3): 285–290. doi:10.1007/BF02411252. PMID 6809291. S2CID 22706943.
Luchin A, Purdom G, Murphy K, Clark MY, Angel N, Cassady AI, et al. (March 2000). "The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts". Journal of Bone and Mineral Research. 15 (3): 451–460. doi:10.1359/jbmr.2000.15.3.451. PMID 10750559. S2CID 24064612.
Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, et al. (December 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–676. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971. S2CID 24698373.
Angel NZ, Walsh N, Forwood MR, Ostrowski MC, Cassady AI, Hume DA (January 2000). "Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover". Journal of Bone and Mineral Research. 15 (1): 103–110. doi:10.1359/jbmr.2000.15.1.103. PMID 10646119. S2CID 35584934.
Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, et al. (February 2011). "Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity". Nature Genetics. 43 (2): 132–137. doi:10.1038/ng.749. PMID 21217752. S2CID 205357235.
Darden AG, Ries WL, Wolf WC, Rodriguiz RM, Key LL (May 1996). "Osteoclastic superoxide production and bone resorption: stimulation and inhibition by modulators of NADPH oxidase". Journal of Bone and Mineral Research. 11 (5): 671–675. doi:10.1002/jbmr.5650110515. PMID 9157782. S2CID 32443917.

zenodo.org

Fenton HJ (1894). "LXXIII.—Oxidation of tartaric acid in presence of iron". Journal of the Chemical Society, Transactions. 65: 899–910. doi:10.1039/CT8946500899.